Thursday, October 15, 2026
  • About Web3Wire
  • Web3Wire NFTs
  • .w3w TLD
  • $W3W Token
  • Web3Wire DAO
  • Media Network
  • RSS Feed
  • Contact Us
Web3Wire
No Result
View All Result
  • Home
  • Web3
    • Latest
    • AI
    • Business
    • Blockchain
    • Cryptocurrencies
    • Decentralized Finance
    • Metaverse
    • Non-Fungible Token
    • Press Release
  • Technology
    • Consumer Tech
    • Digital Fashion
    • Editor’s Choice
    • Guides
    • Stories
  • Coins
    • Top 10 Coins
    • Top 50 Coins
    • Top 100 Coins
    • All Coins
  • Exchanges
    • Top 10 Crypto Exchanges
    • Top 50 Crypto Exchanges
    • Top 100 Crypto Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks
  • Events
  • News
    • Latest Crypto News
    • Latest DeFi News
    • Latest Web3 News
  • Home
  • Web3
    • Latest
    • AI
    • Business
    • Blockchain
    • Cryptocurrencies
    • Decentralized Finance
    • Metaverse
    • Non-Fungible Token
    • Press Release
  • Technology
    • Consumer Tech
    • Digital Fashion
    • Editor’s Choice
    • Guides
    • Stories
  • Coins
    • Top 10 Coins
    • Top 50 Coins
    • Top 100 Coins
    • All Coins
  • Exchanges
    • Top 10 Crypto Exchanges
    • Top 50 Crypto Exchanges
    • Top 100 Crypto Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks
  • Events
  • News
    • Latest Crypto News
    • Latest DeFi News
    • Latest Web3 News
No Result
View All Result
Web3Wire
No Result
View All Result
Home Artificial Intelligence

HorseFil Announces July 2026 Launch of New Gummies Dietary Supplement Formulation

July 26, 2026
in Artificial Intelligence, GlobeNewswire, Web3
Reading Time: 18 mins read
5
SHARES
252
VIEWS
Share on TwitterShare on LinkedInShare on Facebook

AURORA, CO, July 26, 2026 (GLOBE NEWSWIRE) —  Ho seFil has a ou ced the lau ch of its ew gummy dieta y suppleme t fo mulatio , i t oduci g a p oduct desig ed a ou d a combi atio of ami o acids a d bota ical ext acts i a co ve ie t chewable fo mat.

Official Website: https://ho se-fil.us/

The lau ch ep ese ts a ew p oduct i t oductio f om Ho seFil, a compa y based i Au o a, Colo ado, focused o developi g dieta y suppleme t p oducts with clea ly ide tified i g edie ts a d co sume -faci g p oduct i fo matio .

The ewly i t oduced gummy fo mulatio co tai s a ble d of L-Cit ulli e, L-Ca iti e, Pa ax Gi se g Ext act, Maca Root Ext act, Rhodiola Ext act, a d G ape Seed Ext act. The compa y has p ovided i g edie t i fo matio as pa t of its app oach to p oduct t a spa e cy, allowi g co sume s to eview the fo mulatio details befo e use.

Acco di g to Ho seFil, the developme t of the gummy suppleme t eflects co ti ued i te est i co ve ie t dieta y suppleme t fo mats a d clea i g edie t commu icatio . The compa y said the p oduct was c eated with atte tio to fo mulatio desig , i g edie t selectio , a d p ese tatio i a co sume -f ie dly fo mat.

“Ou focus with this lau ch is to p ovide a clea ly labelled dieta y suppleme t optio with a st aightfo wa d i g edie t p ofile,” said a Ho seFil ep ese tative. “We aim to commu icate p oduct i fo matio clea ly a d suppo t i fo med co sume decisio s th ough t a spa e cy.”

P oduct Fo mulatio a d I g edie t I fo matio

The Ho seFil gummy suppleme t featu es a combi atio of ami o acids a d bota ical ext acts commo ly used i the dieta y suppleme t secto .

The fo mulatio i cludes:

L-Cit ulli eL-Cit ulli e is a ami o acid i cluded i va ious ut itio al suppleme t fo mulatio s. It is o e of the i g edie ts selected fo i clusio i the Ho seFil gummy fo mulatio .

L-Ca iti eL-Ca iti e is a ami o acid de ivative commo ly fou d i dieta y suppleme ts. Ho seFil i cludes L-Ca iti e as pa t of its multi-i g edie t fo mulatio app oach.

Pa ax Gi se g Ext actPa ax Gi se g Ext act is a bota ical i g edie t t aditio ally used i va ious cultu es a d commo ly i cluded i suppleme t p oducts.

Maca Root Ext actMaca Root Ext act is de ived f om the maca pla t a d is used as a i g edie t i a a ge of ut itio al fo mulatio s.

Rhodiola Ext actRhodiola Ext act is a bota ical i g edie t f eque tly i co po ated i to dieta y suppleme t p oducts.

G ape Seed Ext actG ape Seed Ext act is a pla t-de ived i g edie t obtai ed f om g ape seeds a d is used i a va iety of suppleme t fo mulatio s.

Ho seFil stated that these i g edie ts we e selected as pa t of the compa y’s p oduct developme t p ocess a d a e disclosed to p ovide co sume s with clea i fo matio about the suppleme t’s compositio .

Focus o I g edie t T a spa e cy

Ho seFil said i g edie t t a spa e cy emai s a impo ta t co side atio i the developme t a d p ese tatio of its p oducts. The compa y oted that co sume s i c easi gly seek detailed i fo matio about suppleme t fo mulatio s, i cludi g i g edie t lists a d p oduct fo mats.

The compa y’s app oach i cludes p ovidi g p oduct details that allow co sume s to eview the fo mulatio a d make decisio s based o thei i dividual eeds a d ci cumsta ces.

Ho seFil advises co sume s to eview p oduct labels ca efully a d co sult healthca e p ofessio als whe co side i g dieta y suppleme ts, pa ticula ly i dividuals who a e p eg a t, u si g, taki g medicatio , o ma agi g a medical co ditio .

Gummy Suppleme t Fo mat

The ew Ho seFil p oduct is p ese ted i gummy fo m, offe i g a alte ative fo mat to t aditio al suppleme t delive y methods such as capsules a d tablets.

The compa y said the gummy fo mat was selected as pa t of its p oduct desig st ategy, p ovidi g co sume s with a diffe e t way to i co po ate a dieta y suppleme t i to thei daily outi es.

Ho seFil stated that p oduct quality, co siste cy, a d accu ate labelli g a e key co side atio s th oughout the p oduct lifecycle, f om fo mulatio developme t th ough fulfilme t.

Compa y Ope atio s

Ho seFil ope ates f om Au o a, Colo ado, USA.

Fulfilme t i fo matio p ovided by the compa y:

Ho seFil (C/O Fulfillme t)19655 E 35th D ive, Suite 100Au o a, CO 80011U ited States

https://ho se-fil.us/

The compa y said its ope atio s a e st uctu ed to suppo t p oduct fulfilme t a d dist ibutio while mai tai i g atte tio to p oduct ha dli g a d custome access.

Suppo ti g Co sume Awa e ess

As pa t of the p oduct i t oductio , Ho seFil emphasised the impo ta ce of espo sible commu icatio a ou d dieta y suppleme ts. The compa y stated that co sume s should co side thei pe so al health ci cumsta ces a d seek p ofessio al guida ce whe e app op iate befo e begi i g a y suppleme t p og amme.

The compa y also highlighted the impo ta ce of eadi g suppleme t labels, u de sta di g i g edie t i fo matio , a d followi g ecomme ded usage i st uctio s.

About Ho seFil

Ho seFil is a dieta y suppleme t compa y based i Au o a, Colo ado, USA. The compa y develops suppleme t p oducts featu i g combi atio s of ami o acids a d bota ical i g edie ts a d focuses o p ovidi g clea p oduct i fo matio a d i g edie t t a spa e cy.

With the i t oductio of its gummy dieta y suppleme t fo mulatio , Ho seFil co ti ues its effo ts to expa d its p oduct a ge while mai tai i g a focus o st aightfo wa d p oduct commu icatio a d co sume i fo matio .

Website: https://ho se-fil.us/

Disclaime : This a ou ceme t elates to a dieta y suppleme t p oduct. Dieta y suppleme ts a e ot i te ded to diag ose, t eat, cu e, o p eve t a y disease. Stateme ts ega di g dieta y suppleme ts have ot bee evaluated by the U.S. Food a d D ug Admi ist atio . Co sume s should co sult a qualified healthca e p ofessio al befo e usi g dieta y suppleme ts, especially if they have existi g health co ditio s o take medicatio .

F eque tly Asked Questio s (FAQ) — Ho seFil Gummy Dieta y Suppleme t

What is Ho seFil?

Ho seFil is a dieta y suppleme t b a d based i Au o a, Colo ado, USA. The compa y has i t oduced a gummy dieta y suppleme t fo mulatio co tai i g a combi atio of ami o acids a d bota ical ext acts.

The p oduct is p ese ted with i g edie t i fo matio to help co sume s u de sta d the fo mulatio a d make i fo med decisio s.

What is the Ho seFil gummy suppleme t fo mat?

The Ho seFil p oduct is available i gummy fo m. The compa y developed the gummy fo mat as a alte ative suppleme t delive y optio fo co sume s who p efe a chewable fo mat.

Whe was the Ho seFil gummy suppleme t lau ched?

Ho seFil a ou ced the i t oductio of its gummy dieta y suppleme t fo mulatio i July 2026.

Whe e is Ho seFil based?

Ho seFil is based i Au o a, Colo ado, U ited States.

The compa y’s fulfilme t i fo matio is:

Ho seFil (C/O Fulfillme t)19655 E 35th D ive, Suite 100Au o a, CO 80011USA

What i g edie ts a e i cluded i the Ho seFil fo mulatio ?

The Ho seFil gummy suppleme t co tai s the followi g i g edie ts:

  • L-Cit ulli e
  • L-Ca iti e
  • Pa ax Gi se g Ext act
  • Maca Root Ext act
  • Rhodiola Ext act
  • G ape Seed Ext act

Co sume s should eview the p oduct label fo the complete i g edie t list a d se vi g i fo matio .

Why does Ho seFil i clude these i g edie ts?

Ho seFil developed the fo mulatio usi g a combi atio of ami o acids a d bota ical ext acts commo ly used i dieta y suppleme t p oducts.

The compa y p ovides i g edie t i fo matio to help co sume s u de sta d the compositio of the p oduct.

Is Ho seFil a medicatio ?

No. Ho seFil is a dieta y suppleme t p oduct a d is ot a medicatio .

Dieta y suppleme ts a e i te ded to suppleme t the diet a d a e ot i te ded to diag ose, t eat, cu e, o p eve t a y disease.

Who should co side usi g a dieta y suppleme t?

I dividuals have diffe e t ut itio al eeds a d ci cumsta ces. Co sume s should co side thei pe so al situatio a d co sult a qualified healthca e p ofessio al whe decidi g whethe a dieta y suppleme t is app op iate fo them.

A e the e a y p ecautio s befo e usi g Ho seFil?

Co sume s should ead the p oduct label befo e use.

I dividuals who a e p eg a t, u si g, taki g p esc iptio medicatio , o ma agi g a medical co ditio should seek advice f om a healthca e p ofessio al befo e usi g a y dieta y suppleme t.

How should co sume s lea mo e about the p oduct?

Co sume s ca eview the available p oduct i fo matio , i g edie t details, a d label i st uctio s p ovided by Ho seFil.

The compa y e cou ages co sume s to u de sta d the p oduct compositio a d usage i fo matio befo e use.

Does Ho seFil make health o medical claims?

Ho seFil p ovides i fo matio about its p oduct fo mulatio a d i g edie ts. Dieta y suppleme ts a e ot i te ded to diag ose, t eat, cu e, o p eve t a y disease.

Co sume s should co sult healthca e p ofessio als fo advice elati g to specific health co ce s.

What makes the Ho seFil fo mulatio diffe e t i te ms of fo mat?

The Ho seFil fo mulatio is p ovided i a gummy fo mat a d combi es ami o acids with bota ical ext acts i a si gle suppleme t p oduct.

The compa y focuses o p ese ti g i g edie t i fo matio clea ly as pa t of its p oduct commu icatio app oach.

How does Ho seFil app oach p oduct i fo matio ?

Ho seFil emphasises clea i g edie t disclosu e a d accessible p oduct i fo matio . The compa y p ovides details about the fo mulatio to suppo t co sume awa e ess.

Whe e ca co sume s fi d i g edie t i fo matio ?

I g edie t i fo matio is p ovided th ough Ho seFil’s p oduct mate ials a d packagi g. Co sume s should efe to the cu e t p oduct label fo the most accu ate a d complete details.

Is Ho seFil suitable fo eve yo e?

Dieta y suppleme ts may ot be suitable fo all i dividuals. Co sume s should eview p oduct i fo matio a d seek p ofessio al advice if they have questio s about whethe a suppleme t is app op iate fo thei ci cumsta ces.

Does Ho seFil eplace a bala ced diet?

No. Dieta y suppleme ts a e i te ded to compleme t a bala ced diet a d healthy lifestyle. They should ot be co side ed a eplaceme t fo va ied ut itio o p ofessio al healthca e advice.

What is the pu pose of the Ho seFil p oduct lau ch?

The July 2026 lau ch i t oduces Ho seFil’s gummy dieta y suppleme t fo mat a d p ovides co sume s with a p oduct co tai i g a clea ly ide tified combi atio of ami o acids a d bota ical ext acts.

About Ho seFil

Ho seFil is a dieta y suppleme t compa y based i Au o a, Colo ado, USA. The compa y develops suppleme t fo mulatio s featu i g selected i g edie ts a d focuses o p ovidi g clea p oduct i fo matio a d i g edie t t a spa e cy.

About Web3Wire
Web3Wire – Information, news, press releases, events and research articles about Web3, Metaverse, Blockchain, Artificial Intelligence, Cryptocurrencies, Decentralized Finance, NFTs and Gaming.
Visit Web3Wire for Web3 News and Events, Block3Wire for the latest Blockchain news and Meta3Wire to stay updated with Metaverse News.

ShareTweet1ShareSendShare2
Previous Post

AAEON Prioritizes Durability with the Release of New COM Express Type 6 Modules

Next Post

SodaSlim Updated Announces July 2026 Launch of New Gummies Dietary Supplement Formulation

Related Posts

Exalate launches Australian hosting for Exalate Cloud, giving organisations the option to run integrations in-country

Local hosti g o Google Cloud i Syd ey is available ow, ac oss eve y Exalate co ecto .ANTWERP, Belgium, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Exalate, the i teg atio solutio fo sy ch o isi g wo k ac oss Ji a, Se viceNow, Azu e DevOps,...

Read moreDetails

Parker to Webcast Annual Meeting of Shareholders on October 28, 2026 at 9:00 a.m. Eastern

CLEVELAND, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Pa ke Ha ifi Co po atio (NYSE: PH), the global leade i motio a d co t ol tech ologies, will webcast its A ual Meeti g of Sha eholde s, which is scheduled fo Wed esday, Octobe 28, 2026, at 9:00...

Read moreDetails

RedCloud Receives Expected Nasdaq Staff Delisting Determination and Files Appeal to Preserve Listing Pending Panel Hearing

As a esult of the appeal, the e is o immediate impact o the listi g of RedCloud o di a y sha es, which co ti ue to t ade i the o mal ma e o the Nasdaq Capital Ma ket u de the symbol “RCT”LONDON, Oct. 14,...

Read moreDetails

Silvaco Announces Date of Third Quarter 2026 Financial Results Conference Call

SANTA CLARA, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Silvaco G oup, I c. (Nasdaq: SVCO) (“Silvaco”), a p ovide of AI-e abled TCAD a d EDA solutio s a d SIP solutio s that e able semico ducto desig a d digital twi modeli g th ough AI softwa...

Read moreDetails

Rapid7 to Report Third Quarter 2026 Financial Results on November 4

BOSTON, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Rapid7, I c. (NASDAQ: RPD), a global leade i AI-powe ed ma aged cybe secu ity ope atio s, today a ou ced that the compa y will elease its thi d qua te 2026 fi a cial esults o Wed esday, Novembe...

Read moreDetails

Datadog Announces Date of Third Quarter Fiscal Year 2026 Earnings Call

NEW YORK, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Datadog, I c. (NASDAQ:DDOG), the leadi g AI-powe ed obse vability a d secu ity platfo m, today a ou ced that it will epo t its thi d qua te fiscal yea 2026 fi a cial esults befo e the U.S....

Read moreDetails

ARRAY Technologies Announces Third Quarter 2026 Earnings Release Date and Conference Call

ALBUQUERQUE, N.M., Oct. 14, 2026 (GLOBE NEWSWIRE) -- ARRAY Tech ologies, I c. (the “Compa y” o “ARRAY”) (NASDAQ: ARRY), a leadi g global p ovide of i teg ated e e gy i f ast uctu e p oducts, softwa e, a d se vice solutio s, today a...

Read moreDetails

Leonardo DRS Expands Federal Access to Mission-Critical Technologies Through NASA SEWP VI

Te -yea p ime co t act p ovides fede al age cies with a st eamli ed path to apidly p ocu e DRS p oducts a d se vices i suppo t of atio al secu ity a d mode izatio missio sARLINGTON, Va., Oct. 14, 2026 (GLOBE...

Read moreDetails

Urozen Capsules Introduces Urozen Multi-Ingredient Dietary Supplement For Prostate Support

U oze Capsules is a me 's well ess dieta y suppleme t featu i g zi c, bota ical ext acts, L-A gi i e HCl, pumpki seed, ettle, a d additio al pla t i g edie ts.Ogde , UT, Oct. 14, 2026 (GLOBE NEWSWIRE) -- U oze...

Read moreDetails

BluSky AI Chief AI Officer to Speak at OCP Global Summit on Open AI Infrastructure Standards

“AI Computi g Co ti uum: Buildi g Ope I f ast uctu e Sta da ds fo the Next Wave of AI”Salt Lake City Utah, Oct. 14, 2026 (GLOBE NEWSWIRE) -- BluSky AI I c. (OTCQB: BSAI), a AI i f ast uctu e compa y focused o modula...

Read moreDetails
Web3Wire NFTs - The Web3 Collective

Web3Wire, $W3W Token and .w3w tld Whitepaper

Web3Wire, $W3W Token and .w3w tld Whitepaper

Claim your space in Web3 with .w3w Domain!

Web3Wire

Trending on Web3Wire

  • Understanding Soulbound Tokens SBT Their Definition and Significance

    82 shares
    Share 33 Tweet 21
  • Top Cross-Chain DeFi Solutions to Watch by 2025

    186 shares
    Share 74 Tweet 47
  • iTrustCapital Launches Q, AI-Formulated Quantitative Trading Strategies for Crypto Investors

    6 shares
    Share 2 Tweet 2
  • Unifying Blockchain Ecosystems: 2024 Guide to Cross-Chain Interoperability

    186 shares
    Share 74 Tweet 47
  • Discover 2025’s Top 5 Promising Low-Cap Crypto Gems

    109 shares
    Share 44 Tweet 27
Join our Web3Wire Community!

Our newsletters are only twice a month, reaching around 10000+ Blockchain Companies, 800 Web3 VCs, 600 Blockchain Journalists and Media Houses.


* We wont pass your details on to anyone else and we hate spam as much as you do. By clicking the signup button you agree to our Terms of Use and Privacy Policy.

Web3Wire Podcasts

Upcoming Events

There are currently no events.

Latest on Web3Wire

  • Exalate launches Australian hosting for Exalate Cloud, giving organisations the option to run integrations in-country
  • Rally Acquires Tenniscores, the League Management Platform Behind 800+ Pickleball, Tennis, Platform Tennis, and Padel Leagues
  • Americas Cardroom Announces Mystery PKO Debut Across Three Halloween Tournaments
  • Americas Cardroom Documentary Examines Chance Kornuth’s WSOP Run and Tournament Re-Entry Debate
  • Parker to Webcast Annual Meeting of Shareholders on October 28, 2026 at 9:00 a.m. Eastern

RSS feed: Latest on Block3Wire Latest on Block3Wire

  • The Algorithmic Monographs: A Five-Volume Civil Code for the Age of Autonomous Intelligence
  • Ali Sadhik Shaik: Practitioner, Scholar, and Author – Focused on the Governance of Intelligent Systems
  • The Klyrox Protocol: A Decentralized Framework to Close the AI Accountability Gap
  • Covo Finance: Revolutionary Crypto Leverage Trading Platform
  • WorldStrides and HEX Announce Partnership to Offer High School and University Students Innovative Courses Designed to Improve Their Outlook in the Digital Age

RSS feed: Latest on Meta3Wire Latest on Meta3Wire

  • The Algorithmic Monographs: A Five-Volume Civil Code for the Age of Autonomous Intelligence
  • Ali Sadhik Shaik: Practitioner, Scholar, and Author – Focused on the Governance of Intelligent Systems
  • The Klyrox Protocol: A Decentralized Framework to Close the AI Accountability Gap
  • Thumbtack Honored as a 2023 Transform Awards Winner
  • Accenture Invests in Looking Glass to Accelerate Shift from 2D to 3D
Web3Wire

Web3Wire is your go-to source for the latest insights and updates in Web3, Metaverse, Blockchain, AI, Cryptocurrencies, DeFi, NFTs, and Gaming. We provide comprehensive coverage through news, press releases, event updates, and research articles, keeping you informed about the rapidly evolving digital world.

  • About Web3Wire
  • Founder’s Note
  • Web3Wire NFTs – The Web3 Collective
  • .w3w TLD
  • $W3W Token
  • Web3Wire DAO
  • Event Partners
  • Community Partners
  • Our Media Network
  • Media Kit
  • RSS Feeds
  • Contact Us

Crypto Coins

  • Top 10 Coins
  • Top 50 Coins
  • Top 100 Coins
  • All Coins – Marketcap
  • Crypto Coins Heatmap

Crypto Exchanges

  • Top 10 Exchanges
  • Top 50 Exchanges
  • Top 100 Exchanges
  • All Crypto Exchanges

Crypto Stocks

  • Blockchain Stocks
  • NFT Stocks
  • Metaverse Stocks
  • Artificial Intelligence Stocks

Web3Wire Whitepaper | Tokenomics

Web3 Resources

  • Top Web3 and Crypto Youtube Channels
  • Latest Crypto News
  • Latest DeFi News
  • Latest Web3 News

Blockchain Resources

  • Blockchain and Web3 Resources
  • Decentralized Finance (DeFi) – Research Reports
  • All Crypto Whitepapers

Metaverse Resources

  • AR VR and Metaverse Resources
  • Metaverse Courses
Claim your space in Web3 with .w3w!

The Klyrox Protocol | The Algorithmic Monographs

Top 50 Web3 Blogs and Websites
Web3Wire Podcast on Spotify Web3Wire Podcast on Amazon Music 
Web3Wire - Web3 and Blockchain - News, Events and Press Releases | Product Hunt
Web3Wire on Google News

Media Portfolio: Block3Wire | Meta3Wire

  • Privacy Policy
  • Terms of Use
  • Disclaimer
  • Sitemap
  • For Search Engines
  • Crypto Sitemap
  • Exchanges Sitemap

© 2024 Web3Wire. We strongly recommend our readers to DYOR, before investing in any cryptocurrencies, blockchain projects, or ICOs, particularly those that guarantee profits.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Coins
    • Top 10 Cryptocurrencies
    • Top 50 Cryptocurrencies
    • Top 100 Cryptocurrencies
    • All Coins
  • Exchanges
    • Top 10 Cryptocurrency Exchanges
    • Top 50 Cryptocurrency Exchanges
    • Top 100 Cryptocurrency Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks

© 2024 Web3Wire. We strongly recommend our readers to DYOR, before investing in any cryptocurrencies, blockchain projects, or ICOs, particularly those that guarantee profits.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.